DR. REDDY S LABORATORIESGiá lên
DRREDDY - Dr Reddy's Laboratories Ltd - Longterm - Bullish
1. Annual Revenue rose 16.78%, in the last year to Rs 25,725 Crores. Its sector's average revenue growth for the last fiscal year was 8.64%.
2. Annual Net Profit rose 106.52% in the last year to Rs 4,507 Crores. Its sector's average net profit growth for the last fiscal year was 2.34%.
3. Debt to Equity Ratio of 0.05 is less than 1 and healthy. This implies that its assets are financed mainly through equity.
4. Interest Coverage Ratio is 51.85, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).
5. Price to Earning Ratio is 19.19, lower than its sector PE ratio of 43.
2. Annual Net Profit rose 106.52% in the last year to Rs 4,507 Crores. Its sector's average net profit growth for the last fiscal year was 2.34%.
3. Debt to Equity Ratio of 0.05 is less than 1 and healthy. This implies that its assets are financed mainly through equity.
4. Interest Coverage Ratio is 51.85, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).
5. Price to Earning Ratio is 19.19, lower than its sector PE ratio of 43.
Thông báo miễn trừ trách nhiệm
Thông tin và ấn phẩm không có nghĩa là và không cấu thành, tài chính, đầu tư, kinh doanh, hoặc các loại lời khuyên hoặc khuyến nghị khác được cung cấp hoặc xác nhận bởi TradingView. Đọc thêm trong Điều khoản sử dụng.